A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two fixed doses (200 Mg or 400 Mg) of DVS-233 SR [desvenlafaxine] in adult outpatients with major depressive disorder.

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two fixed doses (200 Mg or 400 Mg) of DVS-233 SR [desvenlafaxine] in adult outpatients with major depressive disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Depression; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2006 Results have been reported.
    • 08 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top